These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
496 related articles for article (PubMed ID: 27875974)
1. Nanoparticle Systems Modulating Myeloid-Derived Suppressor Cells for Cancer Immunotherapy. Wilkerson A; Kim J; Huang AY; Zhang M Curr Top Med Chem; 2017; 17(16):1843-1857. PubMed ID: 27875974 [TBL] [Abstract][Full Text] [Related]
2. Mechanisms overseeing myeloid-derived suppressor cell production in neoplastic disease. Netherby CS; Abrams SI Cancer Immunol Immunother; 2017 Aug; 66(8):989-996. PubMed ID: 28224211 [TBL] [Abstract][Full Text] [Related]
3. Hampering immune suppressors: therapeutic targeting of myeloid-derived suppressor cells in cancer. Albeituni SH; Ding C; Yan J Cancer J; 2013; 19(6):490-501. PubMed ID: 24270348 [TBL] [Abstract][Full Text] [Related]
4. Myeloid-derived suppressor cells: The green light for myeloma immune escape. Malek E; de Lima M; Letterio JJ; Kim BG; Finke JH; Driscoll JJ; Giralt SA Blood Rev; 2016 Sep; 30(5):341-8. PubMed ID: 27132116 [TBL] [Abstract][Full Text] [Related]
5. Myeloid-Derived Suppressor Cells and Therapeutic Strategies in Cancer. Katoh H; Watanabe M Mediators Inflamm; 2015; 2015():159269. PubMed ID: 26078490 [TBL] [Abstract][Full Text] [Related]
6. IRF7 regulates the development of granulocytic myeloid-derived suppressor cells through S100A9 transrepression in cancer. Yang Q; Li X; Chen H; Cao Y; Xiao Q; He Y; Wei J; Zhou J Oncogene; 2017 May; 36(21):2969-2980. PubMed ID: 28092673 [TBL] [Abstract][Full Text] [Related]
7. Myeloid-derived suppressor cells-a new therapeutic target to overcome resistance to cancer immunotherapy. Chesney JA; Mitchell RA; Yaddanapudi K J Leukoc Biol; 2017 Sep; 102(3):727-740. PubMed ID: 28546500 [TBL] [Abstract][Full Text] [Related]
8. Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression. Groth C; Hu X; Weber R; Fleming V; Altevogt P; Utikal J; Umansky V Br J Cancer; 2019 Jan; 120(1):16-25. PubMed ID: 30413826 [TBL] [Abstract][Full Text] [Related]
9. Glycolysis regulates the expansion of myeloid-derived suppressor cells in tumor-bearing hosts through prevention of ROS-mediated apoptosis. Jian SL; Chen WW; Su YC; Su YW; Chuang TH; Hsu SC; Huang LR Cell Death Dis; 2017 May; 8(5):e2779. PubMed ID: 28492541 [TBL] [Abstract][Full Text] [Related]
10. Suppression of T cells by myeloid-derived suppressor cells in cancer. Chen J; Ye Y; Liu P; Yu W; Wei F; Li H; Yu J Hum Immunol; 2017 Feb; 78(2):113-119. PubMed ID: 27939507 [TBL] [Abstract][Full Text] [Related]
11. Myeloid-derived suppressor cells as effectors of immune suppression in cancer. Pyzer AR; Cole L; Rosenblatt J; Avigan DE Int J Cancer; 2016 Nov; 139(9):1915-26. PubMed ID: 27299510 [TBL] [Abstract][Full Text] [Related]
12. Suppressive role of myeloid-derived suppressor cells (MDSCs) in the microenvironment of breast cancer and targeted immunotherapies. Shou D; Wen L; Song Z; Yin J; Sun Q; Gong W Oncotarget; 2016 Sep; 7(39):64505-64511. PubMed ID: 27542274 [TBL] [Abstract][Full Text] [Related]